Oral polio vaccination and hospital admissions with non-polio infections in Denmark: Nationwide retrospective cohort study

Open Forum Infectious Diseases

Volumn 3, Issue 1, 2016, Pages

  Sørup, Signe ^a   Stensballe, Lone G ^a,b   Krause, Tyra G ^a   Aaby, Peter ^a,c   Benn, Christine S ^a,c,d   Ravn, Henrik ^a,c,d  

^a STATENS SERUM INSTITUT   (Denmark)

^b Rigshospitalet   (Denmark)

^c Studies of the Epidemiology of Epilepsy in Demographic Surveillance Systems   (Guinea-Bissau)

^d UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Heterologous immunity; Immunization; Nonspecific effects; Nontargeted effects; Oral polio vaccination

Indexed keywords

DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; MEASLES MUMPS RUBELLA VACCINE; POLIOMYELITIS VACCINE;

ARTICLE; BIRTH WEIGHT; CHILD; COMPARATIVE STUDY; DENMARK; EMERGENCY WARD; FEMALE; FOLLOW UP; GASTROINTESTINAL INFECTION; GESTATIONAL AGE; HOSPITAL ADMISSION; HUMAN; ICD-10; INFECTION; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; MATERNAL SMOKING; MORBIDITY; MORTALITY; NON POLIO INFECTION; OBSTETRIC DELIVERY; OUTCOME ASSESSMENT; POLIOMYELITIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; VACCINATION;

EID: 85000645660     PISSN: None     EISSN: 23288957     Source Type: Journal    
DOI: 10.1093/ofid/ofv204     Document Type: Article

References (29)

1. Meeting of the Strategic Advisory Group of Experts on immunization, April 2014 -conclusions and recommendations. Wkly Epidemiol Rec 2014; 89:221-36.
2. Systematic review of the non-specific effects of BCG, DTP and measles containing vaccines. Available at: http://www.who.int/immunization/sage/meetings/2014/ april/3_NSE_Epidemiology_review_Report_to_SAGE_14_Mar_FINAL.pdf? ua=1. Accessed 23 October 2014.
3. Contreras G. Effect of the administration of oral poliovirus vaccine on infantile diarrhoea mortality. Vaccine 1989; 7:211-2.
4. Contreras G. Sabin's vaccine used for nonspecific prevention of infant diarrhea of viral etiology. Bull Pan Am Health Organ 1974; 8:123-32.
5. Aaby P, Rodrigues A, Biai S, et al. Oral polio vaccination and low case fatality at the paediatric ward in Bissau, Guinea-Bissau. Vaccine 2004; 22:3014-7.
6. Aaby P, Hedegaard K, Sodemann M, et al. Childhood mortality after oral polio immunisation campaign in Guinea-Bissau. Vaccine 2005; 23:1746-51.
7. Seppala E, Viskari H, Hoppu S, et al. Viral interference induced by live attenuated virus vaccine (OPV) can prevent otitis media. Vaccine 2011; 29:8615-8.
8. Voroshilova MK. Potential use of nonpathogenic enteroviruses for control of human disease. Prog Med Virol 1989; 36:191-202.
9. World Health Organization. Polio Eradication & Endgame Strategic Plan 2013-2018. Available at: http://www.polioeradication.org/Portals/0/Document/ Resources/StrategyWork/PEESP_EN_A4.pdf. Accessed 27 August 2014.
10. Plesner AM, Ronne T. [The childhood vaccination program. Background, status and future]. Ugeskr Laeger 1994; 156:7497-503.
11. Andersen P, Rønne T, Bro-Jørgensen K. Childhood vaccination program -change by July 1, 2001. EPI-NYT 2001; 23.
12. Benn CS, Netea MG, Selin LK, Aaby P. A small jab -a big effect: nonspecific immunomodulation by vaccines. Trends Immunol 2013; 34:431-9.
13. Aaby P, Whittle H, Benn CS. Vaccine programmes must consider their effect on general resistance. BMJ 2012; 344:e3769.
14. Sorup S, Benn CS, Poulsen A, et al. Live vaccine against measles, mumps, and rubella and the risk of hospital admissions for nontargeted infections. JAMA 2014; 311:826-35.
15. Aaby P, Kollmann TR, Benn CS. Nonspecific effects of neonatal and infant vaccination: public-health, immunological and conceptual challenges. Nat Immunol 2014; 15:895-9.
16. Pedersen CB. The Danish Civil Registration System. Scand J Public Health 2011; 39:22-5.
17. Thygesen LC, Ersboll AK. Danish population-based registers for public health and health-related welfare research: introduction to the supplement. Scand J Public Health 2011; 39:8-10.
18. Andersen JS, Olivarius ND, Krasnik A. The Danish National Health Service Register. Scand J Public Health 2011; 39:34-7.
19. Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health 2011; 39:30-3.
20. Kristensen K, Hjuler T, Ravn H, et al. Chronic diseases, chromosomal abnormalities, and congenital malformations as risk factors for respiratory syncytial virus hospitalization: a population-based cohort study. Clin Infect Dis 2012; 54:810-7.
21. Knudsen LB, Olsen J. The Danish Medical Birth Registry. Dan Med Bull 1998; 45:320-3.
22. Baadsgaard M, Quitzau J. Danish registers on personal income and transfer payments. Scand J Public Health 2011; 39:103-5.
23. Jensen VM, Rasmussen AW. Danish Education Registers. Scand J Public Health 2011; 39:91-4.
24. Wojcik OP, Simonsen J, Molbak K, Valentiner-Branth P. Validation of the 5-year tetanus, diphtheria, pertussis and polio booster vaccination in the Danish childhood vaccination database. Vaccine 2013; 31:955-9.
25. Benn CS, Fisker AB, Rodrigues A, et al. Sex-differential effect on infant mortality of oral polio vaccine administered with BCG at birth in Guinea-Bissau. A natural experiment. PLoS One 2008; 3:e4056.
26. Lund N, Andersen A, Monteiro I, et al. No effect of oral polio vaccine administered at birth on mortality and immune response to BCG. A natural experiment. Vaccine 2012; 30:6694-9.
27. Lund N, Andersen A, Hansen AS, et al. The effect of oral polio vaccine at birth on infant mortality: a randomized trial. Clin Infect Dis 2015; 61:1504-11.
28. Martins CL, Benn CS, Andersen A, et al. A randomized trial of a standard dose of Edmonston-Zagreb measles vaccine given at 4.5 months of age: effect on total hospital admissions. J Infect Dis 2014; 209:1731-8.
29. Sorup S, Benn CS, Stensballe LG, et al. Measles-mumps-rubella vaccination and respiratory syncytial virus-associated hospital contact. Vaccine 2015; 33:237-45.